Active surveillance protocol in prostate cancer in Portugal

被引:1
|
作者
Gaspar, S. R. da Silva [1 ]
Fernandes, M. [1 ]
Castro, A. [1 ]
Oliveira, T. [1 ]
Dias, J. Santos [1 ]
dos Reis, J. Palma [1 ]
机构
[1] Ctr Hosp Univ Lisboa Norte, Hosp Santa Maria, Dept Urol, Lisbon, Portugal
来源
ACTAS UROLOGICAS ESPANOLAS | 2022年 / 46卷 / 06期
关键词
Active surveillance; Prostate cancer; Watchful waiting; Portugal; MRI; Biopsy; VERSION; 2; MEN; COMPLICATIONS; MANAGEMENT; BIOPSIES;
D O I
10.1016/j.acuro.2021.01.010
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective: To examine clinical practice patterns in locally managing patients under an active surveillance protocol among Portuguese urologists. Introduction: Prostate cancer (PCa) is a heterogeneous disease with many prostate adeno-carcinomas being indolent and a low probability of ever causing symptoms or death. Active surveillance (AS) is a form of conservative management aimed to reduce over-treatment for low-risk PCa patients. Over the years, experience with AS has grown considerably and is now standard in some countries, however a universal protocol still does not exist. Methods: Nationwide anonymous e-survey concerning habits and practices on AS among Portu-guese urologists, that consisted of 12 questions and was sent electronically to all 368 current members of the Portuguese Urological Association. Results: 56 urologists were surveyed (15.21% answer rate), evenly distributed geographically and allocated according to years of experience as well as number of PCa patients managed monthly. The vast majority of respondents recommends AS to their patients, particularly ISUP grade 1 patients, whose PSA serum level is bellow 20ng/mL. Observance of AS programs by patients was not in question but concerns exist over psychological morbidity while harboring disease. Majority believed that international guidelines surveillance protocols were adequate and sufficient, but there are some constraints concerning availability of periodic MRIs and re -biopsy needs. Conclusions: AS seems to be sustained in urologist clinical practice, although patients still lag to adhere and choose for active treatment. AS may not be an easy choice for patients and clinicians due to uncertainty of disease progression, risk of loss to follow-up and repeated biopsies but is also a cause for anxiety, depression, uncertainty and a perception of danger. (c) 2021 AEU. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:329 / 339
页数:11
相关论文
共 50 条
  • [31] Active surveillance for prostate cancer: For whom?
    Klotz, L
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (32) : 8165 - 8169
  • [32] Active surveillance for localized prostate cancer
    Staerman, F.
    Peyromaure, M.
    Irani, J.
    Gaschignard, N.
    Mottet, N.
    Soulie, M.
    Salomon, L.
    PROGRES EN UROLOGIE, 2011, 21 (07): : 448 - 454
  • [33] The Evolution of Active Surveillance for Prostate Cancer
    Moore, Caroline M.
    Parker, Chris
    EUROPEAN UROLOGY, 2015, 68 (05) : 822 - 823
  • [34] Active surveillance for localized prostate cancer
    Tinay, Ilker
    Turkeri, Levent
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2012, 11 (02): : 114 - 118
  • [35] Active surveillance for localized prostate cancer
    Drouin, S. J.
    Roupret, M.
    Hamdy, F.
    Mottet, N.
    PROGRES EN UROLOGIE, 2010, 20 : S181 - S185
  • [36] Active surveillance of prostate cancer: An update
    Chaloupka M.
    Westhofen T.
    Kretschmer A.
    Grimm T.
    Stief C.
    Apfelbeck M.
    best practice onkologie, 2019, 14 (10) : 442 - 451
  • [37] The inconveniences of active surveillance in prostate cancer
    Sanchez-de-Badajoz, E.
    ACTAS UROLOGICAS ESPANOLAS, 2016, 40 (02): : 69 - 71
  • [38] Active surveillance for patients with localized prostate cancer. Adherence and protocol drop analysis
    Marcos Asensio, Sara
    Virseda Rodriguez, Alvaro Julio
    Martin Izquierdo, Maria Manuela
    Herrero Polo, Manuel
    Coderque Mejia, Monica Paola
    Rocha de Lossada, Alberto
    Hinchado Morgado, Sara
    Noya Mourullo, Andrea
    Garcia Gomez, Francisco
    Hernandez Sanchez, Teresa
    Antunez Plaza, Patricia
    Garcia Garcia, Javier
    Martin-Vallejo, Javier
    Gomez Veiga, Francisco
    ARCHIVOS ESPANOLES DE UROLOGIA, 2021, 74 (05): : 477 - 487
  • [39] Impact of prostate volume on the active surveillance in prostate cancer
    Beaujouan, Florent
    Bertherat, Walter
    Hammoudi, Zakaria
    Chicaud, Marie
    Descazeaud, Aurelien
    JOURNAL OF CLINICAL UROLOGY, 2024,
  • [40] Active Surveillance or Active Treatment in Localized Prostate Cancer?
    Weissbach, Lothar
    Altwein, Jens
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2009, 106 (22): : 371 - I